Valeant injects more cash into bid for Botox-maker Allergan

Dear LOYAL READERS,
FREE EBOOK FOR YOU

Title : 10 Golden Rules Of Investing In Stock Market

Please signup with your email, below.

We respect your email privacy

Subscriber Counter

Value of cash component increased by more than 23% as latest bid values firm at around $ 53 billion.

FORTUNE — Valeant Pharmaceuticals has raised the cash portion of its takeover offer for Botox-maker Allergan for the second time this week in the hopes of kicking off negotiations between the two companies.

Valeant and Allergan’s largest shareholder, Pershing Square Capital, said in a joint announcement Friday afternoon that they have increased the cash component of MORE
Fortune Finance: Hedge Funds, Markets, Mergers & Acquisitions, Private Equity, Venture Capital, Wall Street, Washington

Comments are closed.